AU Patent

AU2014230834A1 — Injectable morphine formulations

Assigned to Fresenius Kabi Deutschland GmbH · Expires 2015-09-10 · 11y expired

What this patent protects

Provided herein, generally, are pharmaceutical formulations,

USPTO Abstract

Provided herein, generally, are pharmaceutical formulations,

Drugs covered by this patent

chembl-chembl2103744 (MORPHINE SULFATE)

Patent Metadata

Patent number: AU2014230834A1
Jurisdiction: AU
Classification: —
Expires: 2015-09-10
Drug substance claim: No
Drug product claim: No
Assignee: Fresenius Kabi Deutschland GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.